首页> 外文期刊>Bangladesh Journal of Veterinary Medicine >EVALUATION OF MATERNALLY DERIVED ANTIBODIES AGAINST NEWCASTLE DISEASE VIRUS AND ITS EFFECT ON VACCINATION IN BROILER CHICKS
【24h】

EVALUATION OF MATERNALLY DERIVED ANTIBODIES AGAINST NEWCASTLE DISEASE VIRUS AND ITS EFFECT ON VACCINATION IN BROILER CHICKS

机译:鸡新城疫病毒原源性抗体的评价及其对雏鸡免疫接种的影响

获取原文
           

摘要

Normal 0 MicrosoftInternetExplorer4 The study was conducted to determine the persistence of maternally derived antibody (MDA) and its effects on protection against NDV in broiler chickens and to investigate the status of humoral immune response following vaccination with BCRDV ® (F-strain, lentogenic) at different ages of broiler chickens during the period from August to October,  2008. A total of 90 day-old broiler chicks of Cobb 500 strain with the history of vaccination of parent stock against Newcastle disease (ND) was divided into three groups (A, B and C). Birds of group A (n = 35) were used for the study of protection ability of MDA against NDV, the birds of group B (n = 45) were used for the measurement of humoral immune response in chickens following vaccination at different ages and birds of group C (n = 10) were used for the determination of persistence of maternally derived antibody. The level of antibody titre against NDV was determined by HI test. The protective potentiality of MDA and vaccine was determined by the rate of survivability of the chickens following challenge infection. It was observed that the MDA titre in day-old chicks was higher and gradually declined at minimal level at day 28. The MDA titre of 128 or above protected the birds following challenge infection with virulent NDV. There were significant decrease in HI titres of chickens which were vaccinated once at day 1 and day 7, and could not withstand challenge infection with virulent NDV. Single vaccination with BCRDV ® at day 14 triggered the production of antibody but could not provide complete protection to the birds. The birds which were boosted with the same vaccine 7 days and 21 days after primary vaccination produced better immune response. However, the birds which were vaccinated primarily at day 1 and boosted at day 7 could not withstand the challenge completely. Of the other regimens of twice vaccination, primary vaccination at day 7 and booster dosing at day 28 was found to be the best in terms of immune response and protection potentiality. Therefore, it may be concluded that (a) The MDA titre level of 128 or above is sufficient to protect broilers against challenge with virulent NDV,( b) Primary vaccination at day 7 followed by a booster dosing at day 28 may be followed for better immune response and protection against ND in broilers. DOI: 10.3329/bjvm.v7i2.5995 Bangl. J. Vet. Med . (2009). 7(2) : 296 – 302
机译:正常0 MicrosoftInternetExplorer4进行本研究旨在确定母源抗体(MDA)的持久性及其对肉鸡NDV保护的影响,并调查在BCRDV®(F株,lentogenic)疫苗接种后的体液免疫应答状态。 2008年8月至10月期间的不同年龄的肉鸡。将90头Cobb 500品系的有雏鸡接种新城疫(ND)病史的肉鸡分为三组(A, B和C)。 A组(n = 35)的鸟类用于研究MDA对NDV的保护能力,B组(n = 45)的鸟类用于测量不同年龄和疫苗接种后的鸡体液免疫反应C组中的一组(n = 10)用于确定母源抗体的持久性。通过HI试验确定抗NDV的抗体滴度水平。通过攻击感染后鸡的存活率来确定MDA和疫苗的保护潜力。观察到,日龄雏鸡的MDA滴度较高,并在第28天以最低水平逐渐下降。MDA滴度为128或更高时,用强毒NDV感染后能保护家禽。在第1天和第7天接种一次疫苗的鸡的HI滴度显着降低,并且不能耐受强毒NDV的激发感染。在第14天用BCRDV®进行单次疫苗接种会触发抗体的产生,但不能为禽鸟提供完全的保护。初次接种疫苗后7天和21天用相同疫苗加强免疫的家禽产生更好的免疫反应。但是,在第1天主要接种疫苗并在第7天加强免疫的鸡无法完全承受挑战。在其他两次免疫接种方案中,就免疫反应和保护潜力而言,在第7天进行初次疫苗接种并在第28天进行加强剂量治疗是最佳的。因此,可以得出以下结论:(a)MDA滴度水平为128或更高足以保护肉鸡免受强毒NDV的攻击。(b)在第7天进行初次疫苗接种,然后在第28天进行加强剂量接种可以更好肉鸡的免疫应答和抗ND的保护作用。 DOI:10.3329 / bjvm.v7i2.5995 Bangl。 J.兽医Med。 (2009)。 7(2):296 – 302

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号